SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-026066
Filing Date
2020-05-19
Accepted
2020-05-19 07:30:40
Documents
13
Period of Report
2020-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20200518.htm   iXBRL 8-K 55193
2 EX-99.1 flxn-ex991_6.htm EX-99.1 393297
  Complete submission text file 0001564590-20-026066.txt   610738

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200518.xsd EX-101.SCH 5804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200518_lab.xml EX-101.LAB 19474
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200518_pre.xml EX-101.PRE 11651
12 EXTRACTED XBRL INSTANCE DOCUMENT flxn-8k_20200518_htm.xml XML 3546
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 20891580
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences